Bacterial Contamination of Blood Products

Rossi's Principles of Transfusion Medicine: Fourth Edition

Volumn , Issue , 2009, Pages 773-790

  Park, Yara A ^a   Brecher, Mark E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991461075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303513.ch49     Document Type: Chapter

References (140)

1. Bacterial contamination of blood components. Association Bulletin #96-6. Bethesda, MD: AABB, 1996.
2. Niu MT, Knippen M, Simmons L, et al. Transfusion-transmitted Klebsiella pneumoniae fatalities, 1995 to 2004. Transfus Med Rev 2006;20:149-57.
3. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001,41:1493-9.
4. Theakston EP, Morris AJ, Streat SJ, et al. Transfusion transmitted Yersinia enterocolitica infection in New Zealand. Aust N Z Med 1997;27:62-7.
5. Perez P, Salmi LR, Follea G, et al. Determinants of transfusion-associated bacterial contamination: Results of the French BACTHEM case-control study. Transfusion 2001,41:862-71.
6. Serious Hazards of Transfusion (SHOT) report for 2004-2005. Manchester, UK: SHOT Office, 2005. [Available at http://www.sho- tuk.org/home.htm.]
7. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18:195-204.
8. Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusion-United States, 1991. MMWR Morb Mortal Wkly Rep 1991;40:176-8.
9. Tipple MA, Bland LA, Murphy JJ, et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 1990;30:207-13.
10. Red blood cell transfusions contaminated with Yersinia enterocolitica-United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997;20;46:553-5.
11. Arduino MJ, Bland LA, Tipple MA, et al. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 1989;27:1483-5.
12. Hogman CF, Fritz H, Sandberg L. Post-transfusion Serratia marces- cens septicemia (editorial). Transfusion 1993;33:189-91.
13. Heltberg O, Show F, Gerner-Smidt P et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993;33:221-7.
14. Szewzyk U, Szewzyk R, Stenstrom TA. Growth and survival of Serratia marcescens under aerobic and anaerobic conditions in the presence of materials from blood bags. J Clin Microbiol 1993;31:1826-30.
15. Richards C, Kolins J, Trindale CD. Autologous transfusion-transmitted Yersinia enterocolitica (letter). JAMA 1992;268:1541-2.
16. Sire JM, Michelet C, Mesnard R et al. Septic shock due to Yersinia enterocolitica after autologous transfusion (letter). Clin Infect Dis 1993;17:954-5.
17. Haditsch M, Binder L, Gabriel C et al. Yersinia enterocolitica septicemia in autologous blood transfusion. Transfusion 1994;34:907-9.
18. Benavides A, Nicol K, Koranyi K, et al. Yersinia septic shock following an autologous transfusion in a pediatric patient. Tranfus Apher Sci 2003;28:19-23.
19. Duncan KL, Ransley J, Elterman M. Transfusion-transmitted Serratia liquifaciens from an autologous blood unit (letter). Transfusion 1994;34:738-9.
20. Rhame FS, McCullough JJ, Cameron S, et al. Pseudomonas cepacia infections caused by thawing cryoprecipitate in a contaminated water bath (abstract). Transfusion 1979;19:653.
21. Casewell MW, Slater NGP, Cooper JE. Operating theatre water- baths as a cause of Pseudomonas septicemia. J Hosp Infect 1981;2:237-40.
22. McClelland DB. Safety of human albumin as a constituent of biologic therapeutic products. Transfusion 1998;38:690-9.
23. Albumin recall. Lancet 1996;348:1026.
24. Steere AC, Tenney JH, Mackel DC, et al. Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis 1977;135:729-3.
25. Wang SA. Tokars JI. Bianchine PJ, et al. Enterobacter cloacae bloodstream infections traced to contaminated human albumin. Clini Infect Dis 2000;30:35-40.
26. Klein HG, Dodd RY, Ness PM, et al. Current status of microbial contamination of blood components: Summary of a conference. Transfusion 1997;37:95-101.
27. Halpin TJ, Kilker S, Epstein J, et al. Bacterial contamination of platelet pools-Ohio, 1991. MMWR Morb Mortal Wkly Rep 1992;41:36-7.
28. Blajchman MA, Thornley J, Richardson H, et al. Platelet transfusion- induced Serratia marcescens sepsis due to vacuum tube contamination. Transfusion 1979;19:39-44.
29. Engstrand M, Engstrand L, Hogman CF, et al. Retrograde transmission of Proteus mirabilis during platelet transfusion and the use of arbitrarily primed polymerase chain reaction for bacteria typing in suspected cases of transfusion transmission of infection. Transfusion 1995;35:871-3.
30. Morro JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions: A persistent problem. JAMA 1991;266:555-8.
31. Krishnan LS, Brecher ME. Transfusion transmitted bacterial infection. Hematol Oncol Clini of North Am 1995;9:167-85.
32. Chiu EKW, Yuien KY, Lie AKW, et al. A prosective study of symptomatic bacteremia following platelet transfusion and its managment. Transfusion 1994;34:950-4.
33. Claeys H, Verhaegle B. Bacterial screening of platelets (abstract). Vox Sang 2000;78(Suppl 1):374.
34. Schelstaete B, Bijnens B, Wuyts G. Prevalence of bacteria in leucode- pleted pooled platelet concentrates and apheresis platelets: A 3-year experience (abstract). Vox Sang 2000;78(Suppl 1):373.
35. Wendel S, Fontao-Wew Orleansendel R, Germano S, et al. Screening of bacteria for blood component production in a Brazilian blood bank (abstract). Vox Sang 2000;78(Suppl 1):376.
36. Leiby DA, Kerr KL, Campos JM, et al. A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion 1997;37:259-63.
37. Dykstra A, Jacobs M, Yomtovian R. Prospective microbiologic surveillance (PMS) of random donor (RDP) and single donor apheresis (SDP) platelets (abstract). Transfusion 1998;38(Suppl): 104S.
38. Blajchman MA, Ali A, Lyn P, et al. Bacterial surveillance of platelets concentrates: Quantitation of bacterial load (abstract). Transfusion 1997;37(suppl):74S.
39. Department of Health and Human Services. The 2007 National Blood Collection and Utilization Survey Report. Washington, DC: DHHS, 2008.
40. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001;18:11-24.
41. Engelfriet CP, Reesink HW, Blajchman MA, et al. Bacterial contamination of blood components. Vox Sang 2000;78:59-67.
42. Shulman, IA. College of American Pathologists Laboratory Accreditation checklist item TRM.44955. Arch Pathol Lab Med 2004;128:958-63.
43. Silva MA, ed. Standards for blood banks and transfusion services. 24th ed. Bethesda,MD: AABB, 2006.
44. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005;45:1845-52.
45. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apher- esis platelets and the residual risk of septic transfusion reactions: The American Red Cross experience (2004-2006). Transfusion 2007;47:1134-42.
46. Palavecino EL, Yomtovian RA, Jacobs MR. Detecting bacterial contamination in platelet products. Clin Lab 2006;52:443-56.
47. Yomtovian R, Tomasulo P, Jacobs MR. Platelet bacterial contamination: Assessing progress and identifying quandaries in a rapidly evolving field. Transfusion 2007;47:1340-6.
48. Grossman BJ, Kollins P, Lau PM, et al. Screening blood donors for gastrointestinal illness: A strategy to eliminate carriers of Yersinia entercolitica. Transfusion 1991;31:500-1.
49. Gibson T, Norris W. Skin fragments removed by injection needles. Lancet 1958;ii:983-5.
50. Lilly HA, Lowbury EJL, Wilkins MD. Limits to progressive reduction of resident skin bacteria by disinfecion. J Clin Pathol 1979;32:382-5.
51. Anderson KC, Lew MA, Gorgone BC, et al. Transfusion-related sepsis after prolonged platelet storage. Am J Med 1986;81:405-11.
52. Goldman M, Roy G, Frechette N, et al. Evaluation of donor skin disinfection methods. Transfusion 1997;37:309-12
53. McDonald CP, Lowe P, Roy A, et al. Evaluation of donor arm disinfection techniques. Vox Sang 2001;80:135-41.
54. Olthuis H, Putlaert C, Verhagen C, et al. A simple method to remove contaminating bacteria during venipuncture (abstract). Vox Sang 1996;70:(Suppl):113.
55. de Korte D, Vlaar R, Marcelis J, et al. Reduction of the degree of bacterial contamination for whole blood collections (abstract). Transfusion 2000;40 (Suppl):36S.
56. Bruneau C, Perez P, Chassaigne M, et al. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion 2001;41:74-81.
57. DeKorte D, Marcelis JH, Verhoeven AJ, et al. Diversion of first blood volume results in a reduction of bacterial contamination for whole- blood collections. Vox Sang 2002;83:13-16.
58. Ness PM, Braine HG, Barrasso C, et al. Single donor platelets reduce the risk of septic transfusion reactions (abstract). Transfusion 1999;39(Suppl):89S.
59. Silva MA, Gregory KR, Carr-Greer MA et al. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey. Transfusion 2006;46:636-41.
60. Schrezenmeier H, Walther-Wenke G, Müller TH, et al. Bacterial contamination of platelet concentrates: Results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007;47:644-52.
61. CCBC. FDA committee endorses education and research to combat rare bacterial reaction: Rejects operational changes for now. CCBC Newsletter 1991;May 10:1-4.
62. AABB. FDA Blood Products Advisory Committee supports educational efforts on Yersinia enterocolitica. Blood Bank Week 1991;20:1-3.
63. Jensenius M, Hoel T, Heier HE. Yersinia enterocolitica septicemia after blood transfusion. Tidsskr Nor Laegeforen 1995;115:940-2.
64. Jacobs J, Jamaer D, Vandeven J, et al. Yersinia enterocolitica in donor blood: A case report and review. J Clin Microbiol 1989;27:1119-21.
65. Donegan E, Lenes BA, Tomasulo PA, et al. Transmission of HIV-1 by component type and duration of shelf storage before transfusion (letter). Transfusion 1991;30:851-2.
66. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: Human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994;34:478-83.
67. Brecher NE, Hogan JJ, Boothe G, et al. The use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell reduced and nonreduced platelets. Transfusion 1993;33:450-7.
68. Rhame FS, Root RK, MacLowry JD, et al. Salmonella septicemia from platelet transfusions. Ann Intern Med 1973;78:633-41.
69. Update: Delayed onset Pseudomonasfluorescens bloodstream infections after exposure to contaminated heparin flushes-Michigan and South Dakota, 2005-2006. MMWR Morb Mortal Wkly Rep 2006;55:961-3.
70. oC and treated with second-messenger effectors. Transfusion 1996;36:691-8.
71. Currie LM, Harper JR, Allan H, et al. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 degrees C with retention of in vitro functional activity. Transfusion 1997;37:18-24.
72. Brecher ME, Holland PV, Pineda A, et al. Bacterial growth in inoculated platelets: Implications for bacterial detection and the extension of platelet storage. Transfusion 2000;40:1308-12.
73. Hoppe PA. Interim measures for detection of bacterially contaminated red cell components (editorial). Transfusion 1992;32:199-201.
74. Brecher ME, Foster M, Mair D. Glucose and haemolysis as a rapid soreen for contamination of red blood cells with Yersinia and Serratia. Vox Sang 2001;81:136-8.
75. Brecher ME, Holland PV, Pineda A, et al. Growth of bacteria in inoculated platelets: Implications for bacterial detection and the extension of platelet storage. Transfusion 2000;34:750-5.
76. Kim DM, Brecher ME, Bland LA, et al. Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters. Transfusion 1992;32:658-62.
77. Buchholz DH, AuBuchon JP, Snyder EL, et al. Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion 1992;32:667-72.
78. Gibb AP, Martin Km, Davidson GA, et al. Modeling the growth of Yersinia enterocolitica in donated blood. Transfusion 1994;34:304-10.
79. Pietersz RNI, Reesink HW, Pauw W, et al. Prevention of Yersinia enterocolitica growth in red blood cell concentrates. Lancet 1992;340:755-6.
80. Kim DM, Brecher ME, Bland LA, et al. Visual identification of bacterially contaminated red cells. Transfusion 1992;32:221-5.
81. Franzin L, Gioannini P. Growth of Yersinia species in artificially contaminated blood bags. Transfusion 1992;32:673-6.
82. Bradley RM, Gander RM, Patel SK, et al: Inhibitory effect of 0°C storage on the proliferation of Yersinia enterocolitica in donated blood. Transfusion 1992;37:691-5.
83. Pickard C, Herschel L, Seery P, et al. Visual identification of bacterially contaminated red blood cells (abstract). Transfusion 1998;38(Suppl):12S.
84. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228-33.
85. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-9.
86. Chongokolwatana V, Morgan M, Feagin JC, et al. Comparison of microscopy and a bacterial DNA probe for detecting bacterially contaminated platelets (abstract). Transfusion 1993;33(Suppl):50S.
87. Brecher ME, Boothe G, Kerr A. The use of chemiluminescence- linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell-reduced and nonreduced platelets. Transfusion 1993;33:450-7.
88. Arpi M, Bremmelgaard A, Abel Y, et al. A novel screening method for the detection of microbial contamination of platelet concentrates: An experimental pilot study. Vox Sang 1993;65:335-6.
89. Hogman CF, Gong J. Studies of one invasive and two noninvasive methods for detection of bacterial contamination of platelet concentrates. Vox Sang 1994;67:351-5.
90. Cortus M, Chong, Carmen R, Wenz B. A new system to detect bacterial contamination in platelet concentrates (abstract). Transfusion 2000;440(Suppl):36S.
91. Wenz B, Delgiacco G, Cortus MA, et al. A system designed to detect bacterial contamination in platelet concentrates (abstract). Vox Sang 2000;78 (Suppl):65.
92. Wagner S, Robinette D. Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates. Transfusion 1996;36:989-93.
93. Burstain JM, Brecher ME, Workman K, et al. Rapid identification of bacterially contaminated platelets using reagent strips: Glucose and pH analysis as markers of bacterial metabolism. Transfusion 1997;37:255-8.
94. Mhawech PY, Werch J, Stager C, et al. Detecting bacterial contamination in platelet concentrates using reagent strips-application in a major cancer center blood bank (abstract). Transfusion 1999;39 (Suppl):36S-37S.
95. Schmidt M, Hourfar MK, Nico SB, et al. A comparison of three rapid bacterial detection methods under simulated real-life conditions. Transfusion 2006;46:1367-73.
96. Mohammadi T, Pietersz RNI, Vandenbroucke-Grauls C, et al. Detection of bacteria in platelet concentrates: Comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion 2005;45:731-6.
97. Kleinman SH, Kamel HT, Harpool DR, et al. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006;46:1787-94.
98. Pietersz RNI, Engelfreit CP, Reesink HW, et al. Detection of bacterial contamination of platelet concentrates. Vox Sang 2007;93:260-77.
99. Holme S, Bunch C, Selman B. Bacterial contamination in stored platelets: Performance of the Pall eBDS system under routine use conditions (abstract). Vox Sang 2005;89(Suppl 1):194.
100. Fournier-Wirth C, Deschaseaux M, Defer C, et al. Evaluation of the enhanced bacterial detection system for screening of contaminated platelets. Transfusion 2006;46:220-4.
101. Brecher MR, Hay SN, Rose AD, et al. Evaluation of BacT/Alert plastic culture bottles for use in testing whole blood-derived leukore- duced platelet-rich-plasma platelets with a single contaminated unit. Transfusion 2005;45:1512-17.
102. Brecher ME, Hay SN, Rothenberg SJ. Validation of BacT/Alert plastic culture bottles for use in testing whole blood-derived leukoreduced platelet-rich-plasma-derived platelets. Transfusion 2004;44:1174-8.
103. Brecher ME, Hay SN, Rothenberg SJ. Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organism found in PLT components. Transfusion 2004;44:359-63.
104. Brecher ME, Hay SN, Rothenberg SJ. Monitoring of apheresis platelet bacterial contamination with an automated liquid culture system: A university experience. Transfusion 2003;43:974-8.
105. Brecher ME, Heath DG, Hay SN, et al. Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organism found in platelet components. Transfusion 2002;42:774-9.
106. Brecher ME, Means N, Jere CS, et al. Evaluation of an automated culture system for detecting bacterial contamination of platelets: An analysis with 15 contaminating organism. Transfusion 2001;41:477-82.
107. McDonald CP, Hartley S, Orchard K, et al. Evaluation of the 3D BacT/Alert automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 2002;12:303-9.
108. Brecher ME, Hay SN. Investigation of an isolate of Staphylococcus lugdunensis implicated in a platelet fatality: A possible advantage to the use of an anaerobic bottle. Transfusion 2007;47:1390-4.
109. Hay SN, Immel CC, McClannan LS, et al. The introduction of 7-day platelets: A univeristy hospital experience. J Clin Apher 2007;22:283-6.
110. Beckers EAM. Effects of bacterial testing: What risks are remaining? ISBT Science Series 2007;2:30-4.
111. Dzik S, AuBuchon J, Jeffries L, et al. Leukocyte reduction of blood components: Public policy and new technology. Transfus Med Rev. 2000;14:34-52.
112. Leukocyte reduction. Association Bulletin 99-7. Bethesda, MD: AABB,1999.
113. Blajchman MA. The effect of leukodepletion on allogenic donor platelet survival and refractoriness in an animal model. Semin Hematol 1991;28(Suppl):14-17.
114. Brecher ME, Pineda AA, Torloni AS, et al. Prestorage leukocyte depletion: Effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism and in vivo survival. Semin Hematol 1991;28(Suppl):3-9.
115. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
116. Wenz B, Burns ER, Freundlich LF. Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration. Transfusion 1992;32:663-6.
117. Kim DM, Estes TJ, Brecher ME, et al. WBC filtration, blood gas analysis and plasma hemoglobin in Yersinia enterocolitica contaminated red cells (abstract). Transfusion 1992;32(Suppl):41S.
118. Hogman CF, Gong J, Hambraeus A, et al. The role of white cells in the transmission of Yersinia enterocolitica in blood products. Transfusion 1992;32:654-7.
119. AuBuchon JP, Pickard C. White cell reduction and bacterial proliferation (letter). Transfusion 1993;33:533-4.
120. Buchholz DH, AuBuchon JP, Snyder EL, et al. Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 1994;34:852-7.
121. Sherburne B, McCullough A, Dzik WH, et al. Bacterial proliferation in platelet concentrates is unaffected by pre-storage leukocyte depletion (abstract). Blood 1991;78(Suppl):350a.
122. Wenz B, Ciavarella D, Freundlich L. Effect of prestorage white cell reduction on bacterial growth in platelet concentrates. Transfusion 1993;33:520-3.
123. Pietersz RNI, Reesink HW, Dekker MA, et al. Elimination of Yersinia enterocolitica by a 20h hold of whole blood and removal of leukocytes by filtration (abstract). Transfusion 1992;32(Suppl):253S.
124. Seidl S. Syphilis screening in the 1990s. Transfusion 1990;30:773-4.
125. Spangler AS, Jackson JH, Fiumara NJ, et al. Syphilis with a negative blood test reaction. JAMA 1964;189:87-90.
126. Van der Sluis JJ, Onvlee PC, Kothe FCHA, et al. Transfusion syphilis, survival of Treponema pallidum in donor blood I. Report of an orientating study. Vox Sang 1984;47:197-204.
127. Van der Sluis JJ, ten Kate FJW, Vuzevski VD, et al. Transfusion syphilis, survival of Treponema pallidum in donor blood II. Dose dependence of experimentally determined survival times. Vox Sang 1985;49:390-9.
128. Soendjojo A, Boedisantoso M, Ilias MI, et al. Syphilis d'emblee due to a blood transfusion. Br J Venereal Dis 1982;58:149-50.
129. Risseeuw-Appel IM, and Kothe FC. Transfusion syphilis: A case report. Sex Transm Dis 1983;10:200-1.
130. Chambers RW, Foley HT, Schmidt PJ. Transfusion of syphilis by fresh blood components. Transfusion 1969;9:32-4.
131. Quinn TC, Cannon RO, Glasser D, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990;150:1297-302.
132. Nelson KE, Vlahov D, Cohn S, et al. Sexually transmitted diseases in a population of intravenous drug users: Association with serop- ositivity to the human immunodeficiency virus (HIV). J Infect Dis 1991;164:457-63.
133. Potterat JJ. Does syphilis facilitate sexual acquisition of HIV? (letter) JAMA 1987;258:473.
134. Otten MW Jr, Zaidi AA, Peterman TA, et al. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS 1994;8:549-53.
135. Rosenblum L, Darrow W, Witte J, et al. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 1992;267:2477-81.
136. Thomas DL, Cannon RO, Shapiro CN, et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among nonintravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994;169:990-5.
137. Cable RG, Leiby DA. Risk and prevention of transfusion- t ransmitted babesiosis and other tick-borne diseases. Curr Opin Hematol 2003;10:405-11.
138. Gabitzsch ES, Piesman J, Dolan MC, et al. Transfer of Borrelia burgdorferi s.s. infection via blood transfusion in a murine model. J Parasitol 2006;92:869-70.
139. Cable R, Krause P, Badon S, et al. Acute blood donor co-infection with Babesia microti and Borrelia burgdorferi (abstract). Transfusion 1993;33(Suppl):50S.
140. Cable RG, Trouern-Trend J. Tick-borne infections. In: Linden JV, Bianco C, eds. Blood safety and surveillance. New York: Marcel Dekker, 2001:399-422.